Philips Set to Showcase AI-Based Solutions at Arab Health 2020
Company highlights CT, image-guided therapy, and enterprise imaging solutions.
DUBAI – Philips Healthcare is set to highlight several product offerings during the Arab Health 2020 annual meeting.
During the conference, the company will present its artificial intelligence (AI)-based solutions intended to improve patient care and care delivery. The overall goal, according to company information, is to develop integrated solutions that can adapt to customer needs and embed into individual workflows.
Over the next few days, conference attendees will have the opportunity review these Philips products:
- Azurion with FlexArm: This gantry development on Philips’ Azurion platform adds new imaging and patient positioning opportunities. It includes a set of innovations that facilitates performing 2D and 3D imaging across the whole patient.
- IQon Elite Spectral CT: As the industry’s only spectral detector-based CT system, it pairs conventional CT images with layers of spectral results in the same exam, potentially reducing the cost associated with repeat exams.
In addition, the company will showcase:
- Next-generation enterprise imaging informatics, including a suite of integrated products with a comprehensive platform designed to connect clinical capabilities and optimize workflows
- PerformanceBridge, Philips’ vendor-agnostic, integrated, scalable portfolio of analytics, services, and tools that gives hospital departments real-time information for performance improvement
Study: AI-Generated ADC Maps from MRI More Than Double Specificity in Prostate Cancer Detection
June 5th 2025Emerging research showed that AI-generated ADC mapping from MRI led to significant increases in accuracy, PPV and specificity in comparison to conventional ADC mapping while achieving a 93 percent sensitivity for PCa.
Can AI Assessment of PET Imaging Predict Treatment Outcomes for Patients with Lymphoma?
June 2nd 2025The use of adjunctive AI software with pre-treatment PET imaging demonstrated over a fourfold higher likelihood of predicting progression-free survival (PFS) in patients being treated for lymphoma, according to a new meta-analysis.
Lunit Unveils Enhanced AI-Powered CXR Software Update
May 28th 2025The Lunit Insight CXR4 update reportedly offers new features such as current-prior comparison of chest X-rays (CXRs), acute bone fracture detection and a 99.5 percent negative predictive value (NPV) for identifying normal CXRs.
